{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["Adjuvant therapy", "COVID-19", "Integrative medicine", "Ozone", "SARS-CoV-2"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "35803132", "DateCompleted": {"Year": "2022", "Month": "08", "Day": "17"}, "DateRevised": {"Year": "2023", "Month": "04", "Day": "24"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2022", "Month": "07", "Day": "04"}], "ELocationID": ["10.1016/j.intimp.2022.109014", "S1567-5769(22)00498-2"], "Journal": {"ISSN": "1878-1705", "JournalIssue": {"Volume": "110", "PubDate": {"Year": "2022", "Month": "Sep"}}, "Title": "International immunopharmacology", "ISOAbbreviation": "Int Immunopharmacol"}, "ArticleTitle": "Ozone as an adjuvant therapy for COVID-19: A systematic review and meta-analysis.", "Pagination": {"StartPage": "109014", "MedlinePgn": "109014"}, "Abstract": {"AbstractText": ["Ozone adjuvant in COVID-19 management showed conflicting results in prior studies. Here, we aimed to comprehensively evaluate benefits and side effects of ozone as adjuvant therapy in COVID-19 patients.", "Systematic searches were conducted in MEDLINE, ScienceDirect, Cochrane Library, Springer, medRxiv, and ProQuest for articles investigating ozone as adjuvant therapy in COVID-19. Clinical and laboratory outcomes, mortality, length of hospital stay, intensive care unit (ICU) admission, and adverse events were assessed.", "Thirteen studies were included in this review. Case-control studies, but not randomized controlled trials (RCTs), showed a decrease in mortality following ozone therapy (OR\u00a0=\u00a00.24 (95% CI [0.07-0.76]), p\u00a0=\u00a00.02, I<sup>2</sup>\u00a0=\u00a00%, fixed-effect). However, ozone therapy did not improve the length of hospital stay (SMD\u00a0=\u00a0-0.99 (95\u00a0%CI -2.44 to 0.45), p\u00a0=\u00a00.18, I<sup>2</sup>\u00a0=\u00a084%, random-effects) and ICU admission (RR\u00a0=\u00a00.57 (95\u00a0%CI [0.05-6.71]), I<sup>2</sup>\u00a0=\u00a073%, p\u00a0=\u00a00.65, random-effects). Consecutive case control studies suggested that ozone therapy significantly improved levels of D-dimer (p\u00a0=\u00a00.0060), lactate dehydrogenase (LDH; p\u00a0=\u00a00.0209), C-reactive protein (CRP; p\u00a0=\u00a00.0040) and interleukin (IL)-6 (p\u00a0=\u00a00.0048) as compared to standard therapy alone.", "The beneficial effect of ozone in COVID-19 management seems to be limited to the improvements of laboratory parameters among severe patients, including the reduction of IL-6, LDH, CRP, and D-dimer levels. Meanwhile, other study endpoints, such as mortality, length of stay and ICU admission, were not improved following ozone therapy, although it may partly be due to a shorter duration of viral clearance. Furthermore, no serious adverse event was reported following ozone therapy, suggesting its high safety profile. (PROSPERO ID: CRD42021278018)."], "CopyrightInformation": "Copyright \u00a9 2022 Elsevier B.V. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Medicine, Universitas Airlangga, Indonesia."}], "LastName": "Setyo Budi", "ForeName": "David", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Medicine, Universitas Airlangga, Indonesia."}], "LastName": "Fahmi Rofananda", "ForeName": "Ihsan", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Medicine, Universitas Airlangga, Indonesia."}], "LastName": "Reza Pratama", "ForeName": "Nando", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Cardiology, CARIM School for Cardiovascular Diseases, Maastricht University, the Netherlands; Department of Physiology and Pharmacology, State University of New York (SUNY) Downstate Health Sciences University, NY, USA."}], "LastName": "Sutanto", "ForeName": "Henry", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Medicine, Universitas Airlangga, Indonesia."}], "LastName": "Sukma Hariftyani", "ForeName": "Arisvia", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Medicine, Universitas Airlangga, Indonesia."}], "LastName": "Ratna Desita", "ForeName": "Saskia", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Medicine, Universitas Airlangga, Indonesia."}], "LastName": "Zinedinita Rahmasari", "ForeName": "Aulia", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Internal medicine, Faculty of Medicine, Universitas Airlangga, Indonesia."}], "LastName": "Pudy Asmarawati", "ForeName": "Tri", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Internal medicine, Faculty of Medicine, Universitas Airlangga, Indonesia; Institute of Tropical Disease, Universitas Airlangga, Indonesia; Department of Physiology and Medical Biochemistry, Faculty of Medicine, Universitas Airlangga, Indonesia."}], "LastName": "Agung Waskito", "ForeName": "Langgeng", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Tropical Disease, Universitas Airlangga, Indonesia; Department of Physiology and Medical Biochemistry, Faculty of Medicine, Universitas Airlangga, Indonesia. Electronic address: citrawati.dyah@fk.unair.ac.id."}], "LastName": "Dyah Kencono Wungu", "ForeName": "Citrawati", "Initials": "C"}], "PublicationTypeList": ["Journal Article", "Meta-Analysis", "Systematic Review"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Int Immunopharmacol", "NlmUniqueID": "100965259", "ISSNLinking": "1567-5769"}, "ChemicalList": [{"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Hospitalization"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Intensive Care Units"}, {"QualifierName": [], "DescriptorName": "Length of Stay"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "COVID-19 Drug Treatment"}], "CoiStatement": "The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Li Q., Guan X., Wu P., Wang X., Zhou L., Tong Y., Ren R., Leung K.S.M., Lau E.H.Y., Wong J.Y., Xing X., Xiang N., Wu Y., Li C., Chen Q.i., Li D., Liu T., Zhao J., Liu M., Tu W., Chen C., Jin L., Yang R., Wang Q.i., Zhou S., Wang R., Liu H., Luo Y., Liu Y., Shao G.e., Li H., Tao Z., Yang Y., Deng Z., Liu B., Ma Z., Zhang Y., Shi G., Lam T.T.Y., Wu J.T., Gao G.F., Cowling B.J., Yang B.o., Leung G.M., Feng Z. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N. Engl. J. Med. 2020;382(13):1199\u20131207.", "ArticleIdList": ["PMC7121484", "31995857"]}, {"Citation": "WHO. 2022. Coronavirus disease 2019 (COVID-19) https://www.who.int/emergencies/diseases/novel-coronavirus-2022/situation reportsSituation Report-100."}, {"Citation": "Hern\u00e1ndez A., Papadakos P.J., Torres A., Gonz\u00e1lez D.A., Vives M., Ferrando C., Baeza J. Two known therapies could be useful as adjuvant therapy in critical patients infected by COVID-19. Rev. Espa\u00f1ola Anestesiol. y Reanim. (English Ed. 2020;67(5):245\u2013252.", "ArticleIdList": ["PMC7156242", "32303365"]}, {"Citation": "Yang M., Hu Z., Yue R. Efficacy and safety of Chinese herbal medicine for Coronavirus disease 2019: A protocol for systematic review and meta-analysis. Medicine (Baltimore). 2020;99(22):e20157.", "ArticleIdList": ["32481380"]}, {"Citation": "Simonovich V.A., Burgos Pratx L.D., Scibona P., Beruto M.V., Vallone M.G., V\u00e1zquez C., Savoy N., Giunta D.H., P\u00e9rez L.G., S\u00e1nchez M.D.L., Gamarnik A.V., Ojeda D.S., Santoro D.M., Camino P.J., Antelo S., Rainero K., Vidiella G.P., Miyazaki E.A., Cornistein W., Trabadelo O.A., Ross F.M., Spotti M., Funtowicz G., Scordo W.E., Losso M.H., Ferniot I., Pardo P.E., Rodriguez E., Rucci P., Pasquali J., Fuentes N.A., Esperatti M., Speroni G.A., Nannini E.C., Matteaccio A., Michelangelo H.G., Follmann D., Lane H.C., Belloso W.H. A Randomized Trial of Convalescent Plasma in COVID-19 Severe Pneumonia. N Engl J Med. 2021;384(7):619\u2013629.", "ArticleIdList": ["PMC7722692", "33232588"]}, {"Citation": "Cattel F., Giordano S., Bertiond C., Lupia T., Corcione S., Scaldaferri M., et al. Ozone therapy in COVID-19: A narrative review. Virus Res. 2021;291:198207. doi: 10.1016/j.virusres.2020.198207.", "ArticleIdList": ["10.1016/j.virusres.2020.198207", "PMC7585733", "33115670"]}, {"Citation": "Yousefi B., Banihashemian S.Z., Feyzabadi Z.K., Hasanpour S., Kokhaei P., et al. Potential therapeutic effect of oxygen-ozone in controlling of COVID-19 disease. Med Gas Res. 2022;12(2):33\u201340. doi: 10.4103/2045-9912.325989.", "ArticleIdList": ["10.4103/2045-9912.325989", "PMC8562402", "34677149"]}, {"Citation": "Bocci V.A., Zanardi I., Travagli V. Ozone acting on human blood yields a hormetic dose-response relationship. J Transl Med. 2011;9:66.", "ArticleIdList": ["PMC3125221", "21575276"]}, {"Citation": "Hertanto D.M., Wiratama B.S., Sutanto H., Wungu C.D.K. Immunomodulation as a Potent COVID-19 Pharmacotherapy: Past. Present and Future. J Inflamm Res. 2021;14:3419\u20133428. doi: 10.2147/JIR.S322831.", "ArticleIdList": ["10.2147/JIR.S322831", "PMC8312605", "34321903"]}, {"Citation": "Chirumbolo S., Valdenassi L., Simonetti V., Bertossi D., Ricevuti G., et al. Insights on the mechanisms of action of ozone in the medical therapy against COVID-19. Int Immunopharmacol. 2021;96:107777. doi: 10.1016/j.intimp.2021.107777.", "ArticleIdList": ["10.1016/j.intimp.2021.107777", "PMC8112288", "34020394"]}, {"Citation": "\u015eahin M., Eryilmaz F., Keser \u015eahin H.H. Ozone therapy may be an option for COVID-19 patients. Eur Rev Med Pharmacol Sci. 2021 Mar;25(6):2470\u20132472. doi: 10.26355/eurrev_202103_25407.", "ArticleIdList": ["10.26355/eurrev_202103_25407", "33829430"]}, {"Citation": "Bayarri B., Cruz-Alcalde A., L\u00f3pez-Vinent N., Mic\u00f3 M.M., Sans C. Can ozone inactivate SARS-CoV-2? A review of mechanisms and performance on viruses. J Hazard Mater. 2021 Aug;5(415) doi: 10.1016/j.jhazmat.2021.125658.", "ArticleIdList": ["10.1016/j.jhazmat.2021.125658", "PMC7955572", "33752085"]}, {"Citation": "Page M.J., McKenzie J.E., Bossuyt P.M., et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 2021;372 doi: 10.1136/bmj.n71.", "ArticleIdList": ["10.1136/bmj.n71", "PMC8005924", "33782057"]}, {"Citation": "Sterne J.A.C., Savovic J., Page M.J., Elbers R., Blencowe N., et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366 doi: 10.1136/bmj.l4898.", "ArticleIdList": ["10.1136/bmj.l4898", "31462531"]}, {"Citation": "Sterne J.A.C., Hern\u00e1n M.A., Reeves B.C., Savovi\u0107 J., Berkman N.D., et al. ROBINS-I: a tool for assessing risk of bias in non-randomized studies of interventions. BMJ. 2016;355 doi: 10.1136/bmj.i4919.", "ArticleIdList": ["10.1136/bmj.i4919", "PMC5062054", "27733354"]}, {"Citation": "G. Wells, B. Shea, D. O\u2019Connell, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed Jun 27, 2021."}, {"Citation": "J. Briggs, Institute. Checklist for systematic reviews and research syntheses. Available at: https://jbi.global/critical-appraisal-tools. Accessed Jun 26, 2021."}, {"Citation": "Tascini C., Sermann G., Pagotto A., Sozio E., De Carlo C., Giacinta A., Sbrana F., Ripoli A., Castaldo N., Merelli M., Cadeo B., Macor C., De Monte A. Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience. Intern Emerg Med. 2021;16(3):669\u2013675.", "ArticleIdList": ["PMC7603641", "33131033"]}, {"Citation": "Fern\u00e1ndez-Cuadros M.E., Albaladejo-Flor\u00edn M.J., \u00c1lava-Rabasa S., Gallego-Galiana J., P\u00e9rez-Cruz G.F., Usandizaga-Elio I., Pacios E., Torres-Garc\u00eda D.E., Pe\u00f1a-Lora D., Casique-Bocanegra L., L\u00f3pez-Mu\u00f1oz M.J., Rodr\u00edguez-de-C\u00eda J., P\u00e9rez-Moro O.S. Compassionate Use of Rectal Ozone (O3) in Severe COVID-19 Pneumonia: a Case-Control Study. SN Compr Clin Med. 2021;3(5):1185\u20131199.", "ArticleIdList": ["PMC7984736", "33778374"]}, {"Citation": "Hern\u00e1ndez A., Vi\u00f1als M., Pablos A., Vil\u00e1s F., Papadakos P.J., et al. Ozone therapy for patients with COVID-19 pneumonia: Preliminary report of a prospective case-control study. Int Immunopharmacol. 2021;90:107261. doi: 10.1016/j.intimp.2020.107261.", "ArticleIdList": ["10.1016/j.intimp.2020.107261", "PMC7833586", "33310665"]}, {"Citation": "\u00c7olak \u015e., Gen\u00e7 Yavuz B., Yavuz M., \u00d6z\u00e7elik B., \u00d6ner M., \u00d6zg\u00fcltekin A., \u015eenbayrak S. Effectiveness of ozone therapy in addition to conventional treatment on mortality in patients with COVID-19. Int J Clin Pract. 2021;75(8) doi: 10.1111/ijcp.14321.", "ArticleIdList": ["10.1111/ijcp.14321", "PMC8236993", "33971067"]}, {"Citation": "Sharma A., Shah M., Lakshmi S., Sane H., Captain J., et al. A pilot study for treatment of COVID-19 patients in moderate stage using intravenous administration of ozonized saline as an adjuvant treatment-registered clinical trial. Int Immunopharmacol. 2021;96:107743. doi: 10.1016/j.intimp.2021.107743.", "ArticleIdList": ["10.1016/j.intimp.2021.107743", "PMC8084612", "33984718"]}, {"Citation": "Sozio E., De Monte A., Sermann G., et al. CORonavirus-19 mild to moderate pneumonia Management with blood Ozonization in patients with Respiratory failure (CORMOR) multicentric prospective randomized clinical trial. Int Immunopharmacol. 2021;98:107874. doi: 10.1016/j.intimp.2021.107874.", "ArticleIdList": ["10.1016/j.intimp.2021.107874", "PMC8196321", "34186281"]}, {"Citation": "Araimo F., Imperiale C., Tordiglione P., Ceccarelli G., Borrazzo C., Alessandri F., Santinelli L., Innocenti G.P., Pinacchio C., Mauro V., Recchia G.E., Zancla S., Cal\u00f2 A., Poscia R., Ruberto F., d'Ettorre G., Bilotta F., Mastroianni C., Pugliese F. Ozone as adjuvant support in the treatment of COVID-19: A preliminary report of probiozovid trial. J Med Virol. 2021;93(4):2210\u20132220.", "ArticleIdList": ["33111980"]}, {"Citation": "Shah M., Captain J., Vaidya V., et al. Safety and efficacy of ozone therapy in mild to moderate COVID-19 patients: A phase 1/11 randomized control trial (SEOT study) Int Immunopharmacol. 2021;91:107301. doi: 10.1016/j.intimp.2020.107301.", "ArticleIdList": ["10.1016/j.intimp.2020.107301", "PMC7758022", "33421928"]}, {"Citation": "Hendawy H.A., Mosallam W., Abuelnaga M.E., Sabry A.M. Old Treatment for a New Disease: Can Rectal Ozone Insufflation Be Used for COVID-19 Management? A Case Report [published online ahead of print, 2021 Apr 14]. SN Compr. Clin Med. 2021;3(6):1424\u20131427.", "ArticleIdList": ["PMC8046266", "33875977"]}, {"Citation": "Franzini M., Valdenassi L., Ricevuti G., Chirumbolo S., Depfenhart M., Bertossi D., Tirelli U. Oxygen-ozone (O2\u2013O3) immunoceutical therapy for patients with COVID-19. Preliminary evidence reported. Int Immunopharmacol. 2020 Nov;88 doi: 10.1016/j.intimp.2020.106879.", "ArticleIdList": ["10.1016/j.intimp.2020.106879", "PMC7414302", "32795898"]}, {"Citation": "Hern\u00e1ndez A., Vi\u00f1als M., Isidoro T., Vil\u00e1s F. Potential Role of Oxygen-Ozone Therapy in Treatment of COVID-19 Pneumonia. The American journal of case reports. 2020;21 doi: 10.12659/AJCR.925849.", "ArticleIdList": ["10.12659/AJCR.925849", "PMC7476746", "32804917"]}, {"Citation": "Wu J., Tan C.S., Yu H., Wang Y., Tian Y., et al. Recovery of Four COVID-19 Patients via Ozonated Autohemotherapy. Innovation (N Y). 2020;1(3):100060. doi: 10.1016/j.xinn.2020.100060.", "ArticleIdList": ["10.1016/j.xinn.2020.100060", "PMC7609231", "33169118"]}, {"Citation": "Valdenassi L., Franzini M., Ricevuti G., Rinaldi L., Galoforo A.C., Tirelli U. Potential mechanisms by which the oxygen-ozone (O2\u2013O3) therapy could contribute to the treatment against the coronavirus COVID-19. Eur Rev Med Pharmacol Sci. 2020 Apr;24(8):4059\u20134061. doi: 10.26355/eurrev_202004_20976.", "ArticleIdList": ["10.26355/eurrev_202004_20976", "32374009"]}, {"Citation": "Sarma P., Bhattacharyya A., Kaur H., Prajapat M., Prakash A., Kumar S., Bansal S., Kirubakaran R., Reddy DibbantiHarikrishna, Muktesh G., Kaushal K., Sharma S., Shekhar N., Avti P., Thota P., Medhi B. Efficacy and safety of steroid therapy in COVID-19: A rapid systematic review and Meta-analysis. Indian J Pharmacol. 2020;52(6):535.", "ArticleIdList": ["PMC8092185", "33666200"]}, {"Citation": "Fern\u00e1ndez-Cuadros M.E., Albaladejo-Flor\u00edn M.J., Pe\u00f1a-Lora D., \u00c1lava-Rabasa S., P\u00e9rez-Moro O.S. Ozone (O3) and SARS-CoV-2: Physiological Bases and Their Therapeutic Possibilities According to COVID-19 Evolutionary Stage. SN Compr. Clin. Med. 2020;2(8):1094\u20131102.", "ArticleIdList": ["PMC7340747", "32838159"]}, {"Citation": "Hu B., Huang S., Yin L. The cytokine storm and COVID-19. J Med Virol. 2021;93:250\u2013256. doi: 10.1002/jmv.26232.", "ArticleIdList": ["10.1002/jmv.26232", "PMC7361342", "32592501"]}, {"Citation": "Hirano T., Murakami M. COVID-19: a new virus, but a familiar receptor and cytokine release syndrome. Immunity. 2020;52(5):731\u2013733.", "ArticleIdList": ["PMC7175868", "32325025"]}, {"Citation": "Kim J.S., Lee J.Y., Yang J.W., Lee K.H., Effenberger M., Szpirt W., Kronbichler A., Shin J.I. Immunopathogenesis and treatment of cytokine storm in COVID-19. Theranostics. 2021;11(1):316\u2013329.", "ArticleIdList": ["PMC7681075", "33391477"]}, {"Citation": "Martinezs G., Re L. Rectal administration and its application in ozone therapy. Int J Ozone Ther. 2012;11:41\u201349."}, {"Citation": "A. Schwartz, G.M. Sanchez, F. Sabah, et al., Madrid Declaration on the ozone therapy. 3rd edition. 2020."}, {"Citation": "Wen Q., Liu D., Wang X., Zhang Y., Fang S., et al. Effects of ozone for treating chronically refractory wounds and ulcers: A protocol for systematic review and meta-analysis of randomized clinical trials. Medicine (Baltimore). 2020;99(22):e20457. doi: 10.1097/MD.0000000000020457.", "ArticleIdList": ["10.1097/MD.0000000000020457", "32481453"]}, {"Citation": "Chatterjee K., Wu C.P., Bhardwaj A., Siuba M. Steroids in COVID-19: An overview. Cleve Clin J Med. 2020 doi: 10.3949/ccjm.87a.ccc059.", "ArticleIdList": ["10.3949/ccjm.87a.ccc059", "32819962"]}, {"Citation": "Bocci V. The Potential Toxicity of Ozone: Side Effects and Contraindications of Ozonetherapy. OZONE. 2010 Sep;24:75\u201384. doi: 10.1007/978-90-481-9234-2_7.", "ArticleIdList": ["10.1007/978-90-481-9234-2_7"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "4", "Day": "5"}, {"Year": "2022", "Month": "5", "Day": "31"}, {"Year": "2022", "Month": "6", "Day": "28"}, {"Year": "2022", "Month": "7", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "8", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "7", "Day": "8", "Hour": "18", "Minute": "28"}, {"Year": "2022", "Month": "7", "Day": "4"}], "PublicationStatus": "ppublish", "ArticleIdList": ["35803132", "PMC9250927", "10.1016/j.intimp.2022.109014", "S1567-5769(22)00498-2"]}}], "PubmedBookArticle": []}